Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00012277
DRKS00012277
Active, not recruiting
Phase 1

Preventive Care Infrastructure based On Ubiquitous Sensing - n-of-1 trial - PRECIOUS

niversity of helsinki0 sites6 target enrollmentSeptember 13, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInactivity

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Inactivity
Sponsor
niversity of helsinki
Enrollment
6
Status
Active, not recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 13, 2017
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of helsinki

Eligibility Criteria

Inclusion Criteria

  • •Adult volunteers (\>18 y) who provide informed consent will be eligible to participate in the
  • •study. To be included in the study, an individual must be able to understand English in the mobile
  • •app, have no counter\-indications to PA (physical activity), own a smartphone with compatible operating system (iOS: version 8 or higher; Android: version 4\.1 ‘Jelly Bean’ or higher), be willing to install the PRECIOUS application on said smartphone for a 30\-day period, be willing to complete
  • •questionnaires and interviews before and after the study, and be willing to wear an accelerometer
  • •or activity tracker for the duration of the study.

Exclusion Criteria

  • •Due to possible confounding effects, participants
  • •will be excluded from participating if they have previously used other tools or apps related to
  • •physical activity, lifestyle or healthy diet, which might confound results with PRECIOUS app.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Infrastructure and processes for optimized care of patients with chronic wounds - decentralized and close to regular care in BremeICD-10:E10.54E10.55E10.74E10.75E11.54E11.55E11.74E11.75E12.54E12.55E12.74E12.75E13.54E13.55E13.74E13.75E14.5E14.74E14.75I70.2I70.24I70.25I87.01I87.21L97I83.0I83.2L89.1019L89.2029L89.3039T21.2T21.3T22.2T22.3T23.2T23.3T24.20T24.21T24.3T25.20T25.21T25.3T29.2T29.3T0.2T30.3T31.T21.6T21.7T22.6T22.7T23.60T23.61T23.7T24.60T24.61T25.7T29.6T29.7T30.6T30.7T32.T79.2T79.3T87.4T89.01T89.02T89.03E10-E14I70I87L89T20-T32T79T89T87I83Diabetes mellitusAtherosclerosisOther disorders of veinsDecubitus ulcer and pressure areaBurns and corrosionsCertain early complications of trauma, not elsewhere classifiedComplications peculiar to reattachment and amputationVaricose veins of lower extremities
DRKS00028522Kassenärztliche Vereinigung Bremen (KVHB)760
Completed
Phase 2
m-WELLCARE: An integrated mHealth system for the prevention and care of chronic diseasesHealth Condition 1: null- Adults aged 30 and above with confirmed diagnosis of hypertension and/or diabetes
CTRI/2016/02/006641Wellcome Trust3,600
Recruiting
Not Applicable
IINDIAGONutritional, Metabolic, EndocrinePregnancy and Childbirthtype 2 diabetes, gestational diabetes
PACTR201805003336174Chronic Disease Initiative for Africa,370
Completed
Not Applicable
A SYNDEMIC BASED LINKAGE TO CARE INTERVENTION FOR HIGH RISK MEN WHO HAVE SEX WITH MEexample anxiety disorderPsychosocial problems1000401810002861
NL-OMON43470GGD Amsterdam145
Completed
Not Applicable
Prospective, multi-centre, non-interventional safety trial to collect real-world data on the safety of immunotherapy with Depigoid® Katze in patients with allergic rhinitis/rhino-conjunctivitis with or without controlled asthma due to feline epitheliaallergic rhinitis/rhino-conjunctivitis with or without controlled asthma due to feline epitheliaJ30.3H10.1H10.8Other allergic rhinitisAcute atopic conjunctivitisOther conjunctivitis
DRKS00028182ETI Pharma GmbH102